Motoo Y, Su S B, Xie M J, Taga H, Sawabu N
Department of Internal Medicine and Medical Oncology, Cancer Research Institute, Kanazawa University, Japan.
Int J Pancreatol. 2000 Apr;27(2):123-9. doi: 10.1385/IJGC:27:2:123.
In an attempt to obtain evidence of the beneficial effects of TJ-10, we investigated the gene expression of PAP, an acute phase protein specific for pancreatitis in rat spontaneous chronic pancreatitis.
Four-wk-old male WBN/Kob rats were fed with MB-3 pellet diet containing herbal medicine. There were two administration groups for each drug: the prophylactic group administered from 4-12 wk, and the therapeutic group administered from 12-20 wk. Untreated control rats were fed with MB-3 alone. Histopathologic changes and PAP gene expressions were analyzed at 12 and 20 wk.
In the prophylactic group, TJ-10-treated WBN/Kob rats showed no evidence of pancreatitis, and there was the amelioration of pancreatitis in the pancreata of the rats treated with other herbal medicines except TJ-24 at 12 wk. PAP mRNA was not expressed in the TJ-10-treated rats, and PAP gene expression was suppressed in rats treated with other drugs except TJ-107. In the therapeutic group, the amelioration of pancreatitis was seen only in TJ-10-treated rats, but PAP gene expression was significantly suppressed in the rats treated with all herbal medicines tested, compared with that in untreated control rats.
An herbal medicine Saiko-keishi-to (TJ-10) delayed the onset of chronic pancreatitis in the WBN/Kob rat, and suppressed the pancreatitis-associated protein (PAP) gene expression more significantly than other herbal medicines.
为了获取TJ - 10有益作用的证据,我们研究了大鼠自发性慢性胰腺炎中胰腺炎特异性急性期蛋白PAP的基因表达。
给4周龄雄性WBN/Kob大鼠喂食含草药的MB - 3颗粒饲料。每种药物有两个给药组:预防性给药组从4周龄至12周龄给药,治疗性给药组从12周龄至20周龄给药。未治疗的对照大鼠仅喂食MB - 3。在12周龄和20周龄时分析组织病理学变化和PAP基因表达。
在预防性给药组中,TJ - 10处理的WBN/Kob大鼠未出现胰腺炎迹象,在12周龄时,除TJ - 24外,用其他草药处理的大鼠胰腺中的胰腺炎有所改善。TJ - 10处理的大鼠中未表达PAP mRNA,除TJ - 107外,用其他药物处理的大鼠中PAP基因表达受到抑制。在治疗性给药组中,仅在TJ - 10处理的大鼠中观察到胰腺炎有所改善,但与未治疗的对照大鼠相比,用所有测试草药处理的大鼠中PAP基因表达均显著受到抑制。
草药柴胡桂枝汤(TJ - 10)延缓了WBN/Kob大鼠慢性胰腺炎的发病,并且比其他草药更显著地抑制了胰腺炎相关蛋白(PAP)的基因表达。